These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 22251005)
21. Human papillomavirus vaccines: an update for gynecologists. Ault KA Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145 [TBL] [Abstract][Full Text] [Related]
22. A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005. Calloway C; Jorgensen CM; Saraiya M; Tsui J J Womens Health (Larchmt); 2006 Sep; 15(7):803-9. PubMed ID: 16999634 [TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus vaccines: current status and future prospects. Garland SM; Smith JS Drugs; 2010 Jun; 70(9):1079-98. PubMed ID: 20518577 [TBL] [Abstract][Full Text] [Related]
25. Eradication of cervical cancer: the beginning of the end. Hillemanns P Arch Gynecol Obstet; 2014 Mar; 289(3):477-8. PubMed ID: 24402328 [No Abstract] [Full Text] [Related]
26. Correlating immunity with protection for HPV infection. Frazer I Int J Infect Dis; 2007 Nov; 11 Suppl 2():S10-6. PubMed ID: 18162240 [TBL] [Abstract][Full Text] [Related]
27. Cervical cancer: A comprehensive approach towards extermination. Bava SV; Thulasidasan AK; Sreekanth CN; Anto RJ Ann Med; 2016; 48(3):149-61. PubMed ID: 26911282 [TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. Herrero R J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278 [No Abstract] [Full Text] [Related]
29. [HPV infection in etiology of uterine cervix cancer]. Olejek A Ginekol Pol; 2008 Feb; 79(2):126-32. PubMed ID: 18510092 [TBL] [Abstract][Full Text] [Related]
30. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model. Gomez JA; Lepetic A; Demarteau N BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716 [TBL] [Abstract][Full Text] [Related]
31. [The use of the human papillomavirus vaccine]. Coquin Y; Guyot S; Le Quellec-Nathan M; Houssin D Rev Prat; 2006 Nov; 56(17):1861-2. PubMed ID: 17243380 [No Abstract] [Full Text] [Related]
32. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries. Luciani S; Jauregui B; Kieny C; Andrus JK Immunotherapy; 2009 Sep; 1(5):795-807. PubMed ID: 20636024 [TBL] [Abstract][Full Text] [Related]
34. Less is more: a step in the right direction for human papillomavirus (HPV) vaccine implementation. Wheeler CM J Natl Cancer Inst; 2011 Oct; 103(19):1424-5. PubMed ID: 21908769 [No Abstract] [Full Text] [Related]
35. No Vacillation on HPV Vaccination. Sipp D; Frazer IH; Rasko JEJ Cell; 2018 Mar; 172(6):1163-1167. PubMed ID: 29522737 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Hung CF; Ma B; Monie A; Tsen SW; Wu TC Expert Opin Biol Ther; 2008 Apr; 8(4):421-39. PubMed ID: 18352847 [TBL] [Abstract][Full Text] [Related]
37. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease. Garbuglia AR; Lapa D; Sias C; Capobianchi MR; Del Porto P Front Immunol; 2020; 11():188. PubMed ID: 32133000 [TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus vaccines for cervical cancer. Murakami M; Gurski KJ; Steller MA J Immunother; 1999 May; 22(3):212-8. PubMed ID: 10335480 [TBL] [Abstract][Full Text] [Related]
39. Human papilloma virus vaccines: need to be introduced in India. Verma R; Khanna P Hum Vaccin Immunother; 2013 Jan; 9(1):97-9. PubMed ID: 23108360 [TBL] [Abstract][Full Text] [Related]